Cargando…

N(6)-Methyladenosine Associated Silencing of miR-193b Promotes Cervical Cancer Aggressiveness by Targeting CCND1

OBJECTIVE: Cervical cancer is a frequently encountered gynecological malignancy as a major contributor to cancer-related deaths in women. This study focuses on how miR-193b promotes cervical cancer aggressiveness as well as the role of m(6)A in miR-193b silencing. METHODS: Cervical cancer samples an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chunxian, Liang, Jinxiao, Lin, Shaodan, Wang, Dongyan, Xie, Qingsheng, Lin, Zhongqiu, Yao, Tingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222573/ https://www.ncbi.nlm.nih.gov/pubmed/34178650 http://dx.doi.org/10.3389/fonc.2021.666597

Ejemplares similares

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer
por: Yao, Tingting, et al.
Publicado: (2013)

Methylation‐associated miR‐193b silencing activates master drivers of aggressive prostate cancer
por: Mazzu, Ying Z., et al.
Publicado: (2019)

Downregulation of miR-193a-3p is involved in the pathogenesis of hepatocellular carcinoma by targeting CCND1
por: Wang, Shi-shuo, et al.
Publicado: (2020)

LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis
por: Han, Dongmei, et al.
Publicado: (2017)

MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1
por: Chen, Zhi-Min, et al.
Publicado: (2019)

Epigenetic Silencing of STAT3-Targeted miR-193a, by Constitutive Activation of JAK/STAT Signaling, Leads to Tumor Progression Through Overexpression of YWHAZ in Gastric Cancer
por: Wei, Kuo-Liang, et al.
Publicado: (2021)

PRKCI Mediates Radiosensitivity via the Hedgehog/GLI1 Pathway in Cervical Cancer
por: Wu, Zhuna, et al.
Publicado: (2022)

Survival, treatment pattern, and treatment outcome in patients with cervical cancer metastatic to distant lymph nodes
por: Lin, Haoliang, et al.
Publicado: (2022)

Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways
por: Chen, Kangmei, et al.
Publicado: (2018)

Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
por: Yang, Zhan, et al.
Publicado: (2017)

miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands
por: Naakka, Erika, et al.
Publicado: (2022)

Liquid Biopsy of Extracellular Vesicle-Derived miR-193a-5p in Colorectal Cancer and Discovery of Its Tumor-Suppressor Functions
por: Wei, Rui, et al.
Publicado: (2020)

MiR193a Modulation and Podocyte Phenotype †
por: Jha, Alok, et al.
Publicado: (2020)

A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma
por: Mo, Xiaocong, et al.
Publicado: (2022)

β-Catenin Expression Negatively Correlates with WIF1 and Predicts Poor Clinical Outcomes in Patients with Cervical Cancer
por: Liang, Jinxiao, et al.
Publicado: (2016)

MiR‐193b deregulation is associated with Parkinson's disease
por: Baghi, Masoud, et al.
Publicado: (2021)

Inhibition of the long non‐coding RNA ZFAS1 attenuates ferroptosis by sponging miR‐150‐5p and activates CCND2 against diabetic cardiomyopathy
por: Ni, Tingjuan, et al.
Publicado: (2021)

miRNA-193a-3p Regulates the AKT2 Pathway to Inhibit the Growth and Promote the Apoptosis of Glioma Cells by Targeting ALKBH5
por: Cui, Yong, et al.
Publicado: (2021)

Upregulation of LINC01503 promotes cervical cancer progression by targeting the miR-615-3p/CCND1 axis
por: Feng, Jing, et al.
Publicado: (2021)

Effects of miR-193a and sorafenib on hepatocellular carcinoma cells
por: Salvi, Alessandro, et al.
Publicado: (2013)

MiR‐139‐5p, miR‐940 and miR‐193a‐5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1
por: Li, Peng, et al.
Publicado: (2019)

MiR-181a functions as an oncogene by regulating CCND1 in multiple myeloma
por: Yan, Xiao, et al.
Publicado: (2020)

The role of estrogen deprivation therapy in premenopausal women with primary unresectable intracardiac leiomyomatosis: a systematic review and meta-analysis
por: Liang, Jinxiao, et al.
Publicado: (2021)

ALDH-1-positive cells exhibited a radioresistant phenotype that was enhanced with hypoxia in cervical cancer
por: Yao, Tingting, et al.
Publicado: (2020)

MiR-193-3p inhibits the malignant progression of atherosclerosis by targeting WDR5
por: Yang, Kai, et al.
Publicado: (2022)

Long Non-coding RNA MIR4435-2HG Promotes Colorectal Cancer Proliferation and Metastasis Through miR-206/YAP1 Axis
por: Dong, Xinhua, et al.
Publicado: (2020)

lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer
por: Yu, Gan, et al.
Publicado: (2019)

Epigenetically altered miR-193a-3p promotes HER2 positive breast cancer aggressiveness by targeting GRB7
por: Tang, Yiyin, et al.
Publicado: (2019)

FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell proliferation and migration
por: Li, Chun-Ming, et al.
Publicado: (2023)

Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma
por: Grossi, Ilaria, et al.
Publicado: (2016)

Upregulation of miR‐9 and miR‐193b over human Th17 cell differentiation
por: Shirani, Fahimeh, et al.
Publicado: (2020)

MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2
por: Li, Yan-Li, et al.
Publicado: (2016)

The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features
por: Wang, Lu, et al.
Publicado: (2016)

CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance
por: Yao, Tingting, et al.
Publicado: (2022)

Silencing circOMA1 Inhibits Osteosarcoma Progression by Sponging miR-1294 to Regulate c-Myc Expression
por: Shi, Yubo, et al.
Publicado: (2022)

MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors
por: Torres-Ferreira, Jorge, et al.
Publicado: (2017)

miR-193 expression differentiates telocytes from other stromal cells
por: Cismasiu, VB, et al.
Publicado: (2011)

N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer
por: Jiang, Zhijia, et al.
Publicado: (2022)

MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively
por: Pu, Youguang, et al.
Publicado: (2016)

Low miR-214-5p Expression Correlates With Aggressive Subtypes of Pediatric ALCL With Non-Common Histology
por: Di Battista, Piero, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fv5jenk1qcri8mak3ov392cbgj